REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hemodiaz Life Sciences Private Limited (India)

Main Activities: Irradiation Apparatus Manufacturing
Full name: Hemodiaz Life Sciences Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Hemodiaz Life Sciences Private Limited is an unlisted company, incorporated on 24/07/1998. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U33111DL1998PTC095173 and registration number is 095173. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Plot No. 324, Shiv Vihar West (Behind Sai Baba Mandr), Vikas Nagar
West Delhi; Delhi; Postal Code: 110059

Contact Details: Purchase the Hemodiaz Life Sciences Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Hemodiaz Life Sciences Private Limited report to view the information.
Outstanding Shares:
Purchase the Hemodiaz Life Sciences Private Limited report to view the information.
Registered Capital:
Purchase the Hemodiaz Life Sciences Private Limited report to view the information.
Incorporation Date:
July 24, 1998
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
12.24%
Purchase this report to view the information.
11.35%
Company Performance
Financial values in the chart are available after Hemodiaz Life Sciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-56.44%▼
Total operating revenue
-56.42%▼
Operating profit (EBIT)
-39.68%▼
EBITDA
-36.88%▼
Net Profit (Loss) for the Period
-40.9%▼
Total assets
-0.81%▼
Total equity
10.57%▲
Operating Profit Margin (ROS)
0.57%▲
Net Profit Margin
0.39%▲
Return on Equity (ROE)
-8.36%▼
Debt to Equity Ratio
14.63%▲
Quick Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo